The chip maker based in Cambridge, previously a constituent of the FTSE 100 until 2016, is getting ready to go public in New York.
The chip maker based in Cambridge, previously a constituent of the FTSE 100 until 2016, is getting ready to go public in New York.
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Dax, Dow, Bitcoin, Arkle,
Tirupati Graphite (TGR), the specialist graphite and graphene company, updated on the ongoing developments and operations of the Sahamamy and Vatomina projects in Madagascar.
The newsflow appears to be accelerating at Chaarat Gold (CGH), the AIM-quoted gold mining company with an operating mine in Armenia, and assets at various stages of development in the
Avacta Group (AVCT), a clinical stage oncology drug company, announced that the first-in-human Phase I trial (ALS-6000-101) of AVA6000 Pro-doxorubicin will advance to the fourth dose cohort of patients following
AMTE Power (AMTE), the developer and manufacturer of lithium-ion and sodium-ion battery cells, announced that it has approved a new execution strategy and identified Dundee, Scotland as the preferred site
i3 Energy (I3E), an independent oil and gas company with assets and operations in the UK and Canada, which has ticked all the right stock market boxes over the past
Zak Mir takes a charting perspective on some of the most followed small caps on the London market. Today’s selection includes Alien, Amur, Bens, Chill, Cambridge, IDE, Oxford, Southern, T42,
Stakebuilding / TR1’s can mark the start of a meaningful rally in the stock, apart from the credibility represented by a major investor getting into a small cap stock. This
Expansion of Partnership with Daewoong Pharmaceutical to Include COVID-19 Neutrali s ing Affimer Therapy
Coronavirus (Covid-19) Vaccine Latest Update: AstraZeneca plans to roll out two billion doses of Covid-19 vaccine in September; human trials of Australian vaccine next month